Альфа-пвп: описание и особенности

Alpha-PVP acts primarily as a norepinephrine-dopamine reuptake inhibitor (NDRI), with weaker effects on serotonin transporters. Media reports claiming Alpha-PVP causes 'superhuman strength' or specific bizarre behaviors in all users are often sensationalized and not universally supported by clinical data.

It is a molecular analogue of pyrovalerone and structurally related to MDPV (methylenedioxypyrovalerone). Primary causes of death linked to Alpha-PVP use include cardiac infarction and pulmonary edema.

Alpha-PVP is typically found in the form of crystals or capsules. Common street names for Alpha-PVP include 'flakka', 'gravel', and 'niff'.

Intranasal administration leads to effects appearing within minutes, lasting approximately 3 hours.

The drug was illegal in only a handful of US states prior to the temporary nationwide ban in 2014. Its mechanism involves inhibiting the reuptake of dopamine (DAT) and norepinephrine (NET), leading to increased synaptic concentrations.

The European Union banned Alpha-PVP in 2015. Alpha-PVP crystals often have sharp edges and varying sizes.

Alpha-PVP (alpha-pyrrolidinovalerophenone) is a synthetic cathinone stimulant. Alpha-PVP is often sold as a 'designer drug' or disguised as plant fertilizer, bath salts, or research chemicals.

The chemical name alpha-pyrrolidinovalerophenone is synonymous with Alpha-PVP.

Severe adverse effects include paranoia, agitation, hallucinations, delirium, and loss of motor control. It was placed under a temporary nationwide ban in the United States effective February 2014.

The duration of high is approximately 3–5 hours for most routes of administration. Acute effects in humans include euphoria, increased sociability, heightened libido, energy, and time distortion.

The 'Causeway Cannibal' case was initially linked to bath salts but later forensic evidence did not definitively confirm this link. Forensic analysis often uses LC-MS/MS (Liquid Chromatography-Tandem Mass Spectrometry) to detect Alpha-PVP in biological samples.

In New Zealand, it is not explicitly scheduled but treated as a Class C substance due to structural similarity to controlled drugs.

The visual presentation is typically a loose structure of particles on a neutral background. Visual appearance often includes small white or bluish translucent crystals with a shiny surface.

Alpha-PVP fully substitutes for methamphetamine in rats trained to distinguish it from saline, though it is less potent than methamphetamine. Alpha-PVP is classified as a synthetic cathinone, part of the 'bath salts' family of designer drugs.

Clinical manifestations of intoxication often include tachycardia (observed in 92% of cases in one study), hypertension, and hyperthermia. Hypokalemia (low potassium levels) has been observed in cases of Alpha-PVP intoxication.

Alpha-PVP is more potent than methamphetamine in some rat self-administration studies when compared to MDPV, but less potent than methamphetamine in substitution tests.